69É«ÇéƬ the Program

The three -year hematology and medical oncology fellowship program will provide trainees with the professional knowledge and skills and prepare them for careers in clinical consultative practice and prepare them to successfully become eligible for board certification in Hematology and medical Oncology. The ACGME core competencies and milestones are achieved through a required set of rotations, a didactic curriculum and elective rotations designed to broaden the base of knowledge.

Overall Goals and Objectives

The overall goals of this program are to train competent Hematology and Medical Oncology consultants proficient in providing consultative services to a broad range of hematology and medical oncology in the In-patient and Ambulatory setting, supervise and direct management of cancer patients, integrate ancillary services (social services, Palliative care, Hospice) and Integrate system resources in the comprehensive care of Cancer patients (pharmacy, Social services specialty pharmacy, primary care providers and community providers). Heavy emphasis is laid on cultural competence, cost effective delivery of healthcare, patient safety and clinical outcomes in a diverse patient population (racially, ethnically and financially). Each fellow is expected to participate in scholarly activity.

Specifics Goals of the Training Program 

1. To mentor physicians to become proficient clinicians and consultants in the field of Medical Oncology and Hematology.
2. To instill the skills necessary for life-long self-education to allow for continued success in their chosen careers.
3. To provide a balanced approach between the demands of their profession and other personal needs.
4. To mentor physicians in the acquisition of humanistic qualities and interpersonal skills, cognitive knowledge, clinical experience and procedural skills, along with other professional skills that will enable them to be effective Hematology-Oncology consultants.
5. To instill the desire, and develop the needed skills to teach colleagues, residents, students, and other health care professionals about cancer biology.

Participating Sites

• Mount Sinai Hospital, Chicago (MSH)
• Captain James A. Lovell Federal Health Care Center (FHCC)
• RUSH BMT/Cell Therapy (RUSH)

Core Faculty

• Pam Khosla, MD (MSH)
• Mohammed Kassem, MD (MSH)
• Jaya Sharma, MD (MSH)
• Seshan Subramaniam, MD (MSH)
• Mukta Pant-Purohit, MD (FHCC)
• William Cotter, MD (FHCC)
• Celalettin Ustun, MD (RUSH)